A celiac disease test in the consumer DNA space (e.g., MyBody-X) typically screens for the risk variants HLA-DQ2 and HLA-DQ8. These are necessary but not sufficient for developing celiac disease: about 30 % of the population carry these genes, yet only about 1 % actually develop the condition. A positive genetic result does not mean you have celiac disease – it only indicates an elevated risk. Diagnosis requires additional specific antibodies (tTG-IgA) and a duodenal biopsy while on a gluten-containing diet. Consumer tests often do not report the exact haplotype combination (e.g., homozygous vs. heterozygous), which further stratifies risk. Also, rare HLA-DQ variants are often missing. If you have symptoms (bloating, diarrhea, fatigue), seek medical evaluation before going gluten-free – a diet before diagnosis can skew test results. Evidence: well-established for genetic risk, but the test alone is not diagnostic.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d1c2876fc751022f23453248